Navigation Links
Farewell to TQT studies, new webinar hosted by Xtalks

Toronto, Canada (PRWEB) January 24, 2013

As requirements for cardiac studies tighten, the ICH-E14 guideline is essentially mandated for Thorough QT studies.

However, these studies are expensive and are usually performed late in Phase II or in Phase III, after many subjects have been exposed to an undefined repolarization risk. Also, by using the E-14 approach, a Sponsor will not learn of a drug’s QT liability until after a large expenditure of money and personnel effort.

A better assessment of QT liability can be achieved early in the drug development cycle, at lower cost to the Sponsor and lower risk to the subject. The strategy to achieve these goals will be discussed by the experts in this webinar.

For more information about this event or to register, visit:

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit

Karen Lim (416) 977-6555 ext 227

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. BioPharm Systems to Host Webinar on an Add-On Solution for Oracle Clinical
2. Webinar to Discuss Biosimilar Regulatory Guidelines in India and Emerging Markets
3. Live Webinar on Protection of Phase 1 Research Volunteers
4. Webinar on Clinical, Regulatory and Commercialization Strategies for Rare Diseases
5. The Veterinary Bioscience Institute Announces its January 2013 Webinar Schedule
6. The Veterinary Bioscience Institute Announces an Amazing Series of 41 Webinars for 2013
7. BioPharm Systems to Host Webinar on Self-service Account Management for Oracle Clinical, Remote Data Capture, and Thesaurus Management System
8. Best Practices, LLC Issues New Report and Webinar on Managing Healthcare Reform through Effective Engagement with the Government Ecosystem
9. Webinar Announcement: GenomeSpace: A New Solution for Integrating Genomic Analysis Tools
10. Northeastern University Nanomanufacturing Center Director Ahmed Busnaina to Present Webinar on “The Democratization of Manufacturing”
11. Clinovo Hosted the Fourth Silicon Valley BioTalks on June 6th, 2012
Post Your Comments:
(Date:10/13/2015)... , October 13, 2015 " ... and Forecast 2015 - 2023 " , the ... and is anticipated to reach US$7.59 bn by 2023, expanding at ... 2023. --> " Microbiology Culture Market - Global ... " , the global microbiology culture market was ...
(Date:10/13/2015)... --      Q BioMed Inc (OTC: QBIO), ... a strategic relationship with Wombat Capital, Ltd., a ... France based strategic and scientific advisory firm.. ... collaborative arrangement gives Q BioMed and its stakeholders access ... as long established pharmaceutical industry relationships. The advisors within ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... ... and distributor of automation systems, material handling solutions and components, is opening its ... I-94 near State Street, the facility is Exotic’s second major expansion in Metropolitan ...
(Date:10/13/2015)... , ... October 13, 2015 , ... ... educational opportunities for school age children in the areas of Science, Technology, Engineering ... sectors of the national economy, and the program aims to increase the number ...
Breaking Biology Technology:
(Date:10/6/2015)... 2015  Maverix Biomics, Inc., a leading genomic ... software portfolio with the debut of its RNA-Seq ... in eukaryotes. The software is integrated into the ... analysis solution that leverages proven open-source algorithms and ... efforts. Garry Nolan,s laboratory at ...
(Date:9/30/2015)... , Sept. 30, 2015  The U.S. Court of ... another key ruling in favor of Crossmatch ™, ... fingerprint scanner company Suprema and its U.S. partner Mentalix ... a trade provision that declares it unlawful to engage ... infringing two of Crossmatch,s patents, the 5,900,993 patent and ...
(Date:9/28/2015)...  The monitoring of vital signs, such as ... an essential component of patient assessment. Changes in ... a patient,s condition. However, in general care areas ... during routine observation rounds only once every four ... these observation rounds, the warning signs can go ...
Breaking Biology News(10 mins):